
New Eczema Drug Shows 83% Success After One Year
An experimental eczema treatment called rezpeg helped most patients maintain clear skin for a full year with just quarterly injections. The results could offer millions of eczema sufferers a more convenient alternative to current treatments.
Millions of people with moderate to severe eczema may soon have a new treatment option that works better with fewer doctor visits.
Nektar Therapeutics announced Tuesday that their experimental drug rezpeg kept skin improvements strong in patients for an entire year. The best part? Those getting quarterly injections saw an 83% success rate, while monthly injection patients hit 71%.
The drug met and exceeded what experts expected, positioning it as a serious competitor to Dupixent and Ebglyss, the two most prescribed biologic drugs for eczema today. Eczema, also called atopic dermatitis, causes painful, itchy skin lesions that can dramatically impact quality of life.
"When you compare our results competitively, we're showing better efficacy with less frequent injections," said Dr. Mary Tagliaferri, Nektar's chief medical officer. That means patients could visit their doctor just four times a year instead of every two weeks or monthly, a huge improvement for busy families.

The Ripple Effect
Less frequent dosing means more than just convenience. Fewer clinic visits translate to less time off work, reduced childcare scrambling, and lower transportation costs for families already dealing with the financial burden of chronic illness.
The results also offer hope for the estimated 16.5 million adults in the United States living with atopic dermatitis. Many current treatments require frequent injections or come with challenging side effects that make sticking with therapy difficult.
Rezpeg's ability to maintain stringent skin improvements over a full year shows promise for lasting relief. The maintenance study tracked patients who had already responded well to the drug, proving that the benefits stick around long term.
For people who've cycled through multiple treatments searching for relief, competition in the eczema drug market means more options and potentially better outcomes. When pharmaceutical companies compete on efficacy and convenience, patients win.
Better skin health can transform daily life, from improved sleep to increased confidence in social situations and work environments.
More Images




Based on reporting by STAT News
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it


